Ally Bridge Group »

Tectonic Therapeutic shares owned by Ally Bridge Group

Quarter-by-quarter ownership of Tectonic Therapeutic (TECX) shares owned by Ally Bridge Group from 13F filings

Historical chart of Ally Bridge Group investment in Tectonic Therapeutic

Tip: Access up to 7 years of quarterly data

All positions including Tectonic Therapeutic held by Ally Bridge Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tectonic Therapeutic by Ally Bridge Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.2M 139k 15.69
2025-06-30 $3.3M 164k 19.87
2025-03-31 $2.3M 132k 17.71

More positions owned by Ally Bridge Group

Soleno Therapeutics (SLNO)
Replimune Group Call Option (REPL)
Madrigal Pharmaceuticals (MDGL)
Compass Pathways Sponsored Ads (CMPS)
Atai Beckley Nv SHS (ATAI)
Ascendis Pharma A/s - Sponsored Adr (ASND)
Lenz Therapeutics (LENZ)
Taysha Gene Therapies Com Shs (TSHA)
Amylyx Pharmaceuticals (AMLX)
Eupraxia Pharmaceuticals (EPRX)
Praxis Precision Medicines I Com New Call Option (PRAX)
Monopar Therapeutics Com New (MNPR)
Arcutis Biotherapeutics (ARQT)
Mind Medicine Mindmed Com New (MNMD)
Tarsus Pharmaceuticals (TARS)

View all positions for Ally Bridge Group

Top funds holding Tectonic Therapeutic

FMR
BlackRock
Braidwell
Farallon Capital Management
Vanguard Group
5AM Venture Management
Point72 Asset Management
Prosight Management
Standard Life Aberdeen
Bollard
Citadel Advisors
Geode Capital Management
Pale Fire Capital SE
Polygon Management
Millennium Management

View all funds holding Tectonic Therapeutic